With the deal, clients of both companies will have access to more robust data collection and analysis to help them and their patients to make more informed decisions about patient care options, executives said.
IMI’s national customer base includes health plans, pharmacy benefits managers and health care providers, while Boundary’s clients are mostly providers, clinical research facilities and medical product companies.
Boundary’s operations have relocated to Nashville and its top executives will remain with IMI. They include former Chief Executive Officer Mark Walinske, who’s now chief business development officer for IMI.
IMI is raising expansion capital to build a sales and marketing team to grow the companies, officials said.
Nashville’s Vanguard to buy Detroit Medical CenterFuture Architects Design Sustainabale Architecture
